Belfast firm to partner with QUB to develop humanised therapeutic antibody to combat treatment-resistant cancers ...

The findings, published in Science Advances, highlight how these lab-engineered sEVs target a specific receptor on tumor cells known as DR5 (death receptor 5). This receptor plays a crucial role ...